EGFR and colorectal cancer: Colorectal cancers with V600E BRAF mutations may be treated with combinations of small molecule BRAF inhibitors and anti-EGFR monoclonal antibodies and the less common HER2 over-expressing colorectal cancers may be treated with drugs targeting this alteration [5, 6].